Government Affairs
Refine Search
Generics
Russia is still unable to solve a problem of a shortage of drugs in the domestic pharmaceutical market, while the current situation may further deteriorate in 2020, according to recent statements by some local pharma analysts and producers. 28 January 2020
Pharmaceutical
Rapid report shows how routine practice data should be used and processed. Therefore, first data from high-quality registries will presumably soon be considered in benefit assessment of drugs, says Germany’s Institute for Quality and Efficiency in Health Care (IQWiG) 27 January 2020
Pharmaceutical
As the general election campaign began its second week, the Irish Pharmaceutical Healthcare Association (IPHA) urged all political parties to pledge to improve patients’ access to new medicines as part of their plans for health. 27 January 2020
Pharmaceutical
Years of campaigning for a renewed drive in antibiotic (AB) drug development have not yet delivered a healthy pipeline that will end the crisis soon, says the World Health Organization (WHO). 17 January 2020
Generics
India’ National Pharmaceutical Pricing Authority has allowed both Cipla and Glenmark Pharma to enhance pricing for two of their respiratory products after they were termed innovative compared to other similar products available in the market. 17 January 2020
Pharmaceutical
The Hungarian government’s health department has decided to include 26 new medicinal products and indications into the subsidy system, affecting several therapeutic fields, announced Miklós Kásler, Minister of Human Capacities. 17 January 2020
Pharmaceutical
A higher number of people are currently being diagnosed with cancer in Europe than at any point since 1995, yet fewer of these people are dying of the disease, according to a new study. 16 January 2020
Biotechnology
Swiss pharma giant Novartis has announced a deal with the National Health Service (NHS) that will bring English patients with atherosclerotic cardiovascular disease (ASCVD) access to inclisiran. 14 January 2020
Biosimilars
IGBA, the International Generic and Biosimilar medicines Association (IGBA), representing global manufacturers of generic and biosimilar medicines, has announced that Hanan Sboul, secretary general of the Jordanian Association of Pharmaceutical Manufacturers, is taking over the position of IGBA chairman for 2020 from Jim Keon, president of the Canadian Generic Pharmaceutical Association and Biosimilars Canada. 10 January 2020
Pharmaceutical
A new report into cancer, carried out by the think tank Demos on behalf of Pfizer (NYSE: PFE), finds that the UK lags far behind the rest of Europe in cancer outcomes and spending. 10 January 2020
Pharmaceutical
The revised Intellectual Property Provisions negotiated as part of the Canada US Mexico Agreement (CUSMA) will discourage investment in Canadian health research and hurt our country’s competitiveness, commented Innovative Medicines Canada president Pamela Fralick in a website posting by the trade group. 4 January 2020
Pharmaceutical
Amid the ongoing stagnation of the Russian pharmaceutical market, local drugmakers have significantly increased exports of their drugs, according to recent statements, made by representatives of some leading local pharmaceutical producers and industry analysts, reports The Pharma Letter’s local correspondent. 24 December 2019
Pharmaceutical
Shares of US company Paratek Pharmaceuticals had soared more than 40% to $4.15 by late morning trading today, on the news that it had received a lucrative government contract. 19 December 2019
Pharmaceutical
Impeachment aside, there was some other news surrounding Donald Trump and his Administration on Wednesday. 19 December 2019
Pharmaceutical
Parts of the UK and European pharma and biotech industry have spent significant periods of the last three and a half years preparing for possible Brexit outcomes. 18 December 2019
Pharmaceutical
The European Federation of Pharmaceutical Industries and Associations (EFPIA), together with cancer patient groups, has called for a new European Cancer Plan to help tackle the burden of the disease. 18 December 2019
Generics
India's drug price regulator, the National Pharmaceutical Pricing Authority (NPPA), has raised the ceiling price of 21 essential medicines by 50%. 17 December 2019
Biotechnology
Following Monday morning’s notice of clearance from the UK’s Competition and Markets Authority, later the same day the USA’s Federal Trade Commission revealed closure of its investigation into Swiss pharma giant Roche’s proposed $4.3 billion acquisition of Spark Therapeutics. 17 December 2019
Biotechnology
Roche’s long-delayed $4.3 billion acquisition of Spark Therapeutics, announced in February, moved a step forward to completion, with the news that it has been cleared by the UK’s regulator, though in the USA approval is still awaited,
. 16 December 2019
Pharmaceutical
In Australia, total Pharmaceutical Benefits Scheme (PBS) government expense for the supply of medicines under Section 85 and Section 100 on an accrual accounting basis for the 2018-2019 financial year was A$11,818 million (US$8,193 million), excluding revenue, compared with A$11,690 million for the previous year, an increase of 1.1%. 16 December 2019
Pharmaceutical
The nomination of Robert F Kennedy Jr — known as RFK Jr — for the role of US Secretary of the Department of Health and Human Services (HHS) President-elect Donald Trump sent shares in vaccine companies sharply downwards. 22 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
The Danish government’s newly-unveiled health reform has been praised for tackling chronic disease care and health inequalities while driving health innovation. 18 November 2024
Pharmaceutical
New research published by the European Federation of Pharmaceutical Industries and Associations (EFPIA) provides in-depth analysis of the economic footprint of the pharmaceutical industry in Europe, across member states and compares Europe to other regions of the world. 18 November 2024
Pharmaceutical
Johnson & Johnson has taken legal action to defend a contentious rebate initiative, filing a lawsuit in the US District Court for the District of Columbia. 15 November 2024
Pharmaceutical
The share prices of Pfizer, GSK, Novavax and other vaccine companies were all markedly lower on Friday. This was not due to the publication of disappointing research results in the sphere, or an ominous stance taken by a major regulator on a key filing, but rather a political development that could spell trouble for the vaccines field as a whole. 15 November 2024
Biotechnology
BeiGene has announced plans to rebrand as BeOne Medicines, a move the cancer specialist says reflects its commitment to fighting cancer through collaboration. 15 November 2024
Pharmaceutical
Danish patients are being offered fewer innovative treatments than Norwegians and Swedes, a new estimate from the Danish Medicines Council shows. 11 November 2024
Pharmaceutical
According to the Swedish pharma trade group Lif, it is positive that, in the updated life science strategy, the government expresses an ambition for Sweden to become more attractive for research investments. 11 November 2024
Pharmaceutical
Li Li, Commissioner of China's National Medical Products Administration (NMPA), and Mette Aaboe Hansen, interim director general of Danish Medicines Agency, have signed a letter of intent to promote bilateral cooperation in regulation of drugs and medical devices. 11 November 2024
Pharmaceutical
Following the news that Donald Trump is the winner of the 2024 US Presidential Election, Morningstar Equity analyst Julie Utterback has published a new note about the impact of this on the managed-care industry. 7 November 2024
Pharmaceutical
UK pharma major AstraZeneca, which has invested heavily in China, hosted a sell-side analyst call on Wednesday (November 6) to discuss the recent media reports about ongoing investigations in China. 7 November 2024
Pharmaceutical
Some of the UK’s leading academics and industry professionals have welcomed Chancellor Rachel Reeves’ £520 million ($669 million) pledge to develop the country’s medicine manufacturing capabilities. 6 November 2024
Pharmaceutical
European regulators will decide by December 6 whether Novo Holdings, the controlling shareholder of Danish pharma giant Novo Nordisk, can finalize its $16.5 billion acquisition of contract drug manufacturer Catalent. 5 November 2024
Pharmaceutical
The Danish government is rolling out the red carpet and welcomes several pharmaceutical companies. 4 November 2024
Generics
Medicines for Europe has launched a study of market barriers faced by European generics and biosimilar pharmaceutical companies operating in 11 key third-country markets. 31 October 2024
Pharmaceutical
Following the first Labour budget for 14 years, the Association of the British Pharmaceutical Industry (ABPI) welcomes Chancellor Rachel Reeves’ measures to improve UK life sciences competitiveness. 30 October 2024
Pharmaceutical
HOPO Therapeutics has been awarded a contract valued at up to $226 million from the Biomedical Advanced Research and Development Authority (BARDA). 29 October 2024
Pharmaceutical
The Danish government has presented part of the plan for a future life science strategy, which has been welcomed by the industry. 28 October 2024
Biotechnology
Legend Biotech has removed Genscript Biotech as its majority shareholder, in a move coinciding with rising US concerns over Chinese ties within the biotech sector. 24 October 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
A US biotech company dedicated to creating oral drugs with an emphasis on indications in virology and immunology.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze